AGP Limited (PSX:AGP)

Market Cap	55.70B +2.1%
Revenue (ttm)	28.89B +15.4%
Net Income	3.74B +39.9%
EPS	13.34 +39.9%
Shares Out	280.00M
PE Ratio	14.91
Forward PE	11.92
Dividend	8.00 (4.02%)
Ex-Dividend Date	Apr 13, 2026

Volume	1,225,152
Average Volume	877,862
Open	190.00
Previous Close	189.20
Day's Range	189.38 - 200.48
52-Week Range	142.00 - 258.67
Beta	0.42
RSI	55.82
Earnings Date	Apr 24, 2026

About AGP Limited

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti-epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, atypical antip...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1989
• Employees: 2,143
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: AGP

Financial Performance

In 2025, AGP Limited's revenue was 28.89 billion, an increase of 15.40% compared to the previous year's 25.03 billion. Earnings were 3.74 billion, an increase of 39.91%.